CANDEL THERAPEUTICS INC (CADL) Stock Analyst Earnings Estimates
NASDAQ:CADL - Nasdaq - US1374041093 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 130K | 130K | 130K | -100.00% | 94.35M | 236.23M 150.38% | 417.18M 76.60% | 722.67M 73.23% | 1.097B 51.80% | |||
| EBITDA YoY % growth | -13.72M -52.44% | -25.5M -85.86% | -33.94M -33.10% | -34.996M -9.11% | -45.217M -22.10% | -100.98M -123.33% | 19.584M 119.39% | 123.32M 529.70% | 265.4M 115.21% | 502.55M 89.36% | 790.19M 57.24% | |
| EBIT YoY % growth | -13.81M -52.77% | -25.73M -86.31% | -34.72M -34.94% | -38.046M -9.42% | -35.496M 6.57% | -47.124M -32.76% | -12.036M 74.46% | 89.454M 843.22% | 228.89M 155.87% | 463.08M 102.32% | 746.95M 61.30% | |
| Operating Margin | -10,623.08% | -19,792.31% | -26,707.69% | N/A | N/A | N/A | -12.76% | 37.87% | 54.87% | 64.08% | 68.09% | |
| EPS YoY % growth | N/A | N/A | -1.12 46.21% | -1.11 -21.43% | -1.68 -23.75% | 0.15 109.09% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.31 19.47% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -9.69M 4.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.38 -111.11% | -0.16 | -0.22 | -132.84% |
| Q3 2023 Q2Q % growth | -0.31 -3.33% | -0.19 | -0.12 | -59.96% |
| Q2 2023 Q2Q % growth | -0.34 -6.25% | -0.30 | -0.04 | -11.67% |
| Q1 2023 Q2Q % growth | -0.33 -3.13% | -0.36 | 0.03 | 7.56% |
| Q4 2022 Q2Q % growth | -0.18 -158.06% | -0.32 | 0.14 | 43.44% |
| Q3 2022 Q2Q % growth | -0.30 -15.38% | -0.36 | 0.06 | 16.68% |
| Q2 2022 Q2Q % growth | -0.32 -3.23% | -0.42 | 0.10 | 23.01% |
| Q1 2022 Q2Q % growth | -0.32 | -0.31 | -0.01 | -1.86% |
| Q4 2021 Q2Q % growth | 0.31 | -0.33 | 0.64 | 194.98% |
| Q3 2021 Q2Q % growth | -0.26 | -0.30 | 0.04 | 12.10% |
| Q2 2021 Q2Q % growth | -0.31 | -0.12 | -0.19 | -153.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 30K | 23.123K | 6.877K | 29.74% |
| Q3 2022 Q2Q % growth | 30K | 30.6K | -600 | -1.96% |
| Q2 2022 Q2Q % growth | 30K | 30K | % | |
| Q1 2022 Q2Q % growth | 30K | 15.3K | 14.7K | 96.08% |
| Q4 2021 Q2Q % growth | 30K | 15.3K | 14.7K | 96.08% |
| Q3 2021 Q2Q % growth | 30K | 40.8K | -10.8K | -26.47% |
| Q2 2021 Q2Q % growth | 30K | 20.4K | 9.6K | 47.06% |
| Q1 2021 Q2Q % growth | 30K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -81.32% |
| Revenue | N/A | N/A | N/A | N/A |